Our firm is pleased to present an all cash, extremely high profit margin non-sterile Compounding Pharmacy Opportunity in California doing approximately 16k non-sterile compounds per year. All cash business, no insurance billing. Lease in place until 2024 with option to extend 5 years.
$1.3 million annual revenue with an adjusted EBITDA of ~700k
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.